It is no secret that misinformation about addiction is rampant in popular media. One particular area of misinformation concerns how the use of language is employed when describing topics related to ...

The same drugs that transformed obesity treatment are now being investigated for substance use disorders, fueling interest in ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has strengthened warnings about the risks of dependence, addiction, withdrawal, and tolerance linked to several classes of central ...

Last April, neuroscientist Sue Grigson received an e-mail from a man detailing his years-long struggle to kick addiction — first to opioids, and then to the very medication meant to help him quit. The ...

Drug use appears to be changing in England – both in the types of drugs people take and their potency, according to our latest survey of adult mental health and wellbeing. The Adult Psychiatric ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn't use a patch. He ...

Nearly 50 million over the age of 12 reportedly have substance use disorders, which can include addictions to alcohol or drugs. Other issues that affect millions - such as gambling, shopping, gaming, ...